Skip to main content
. 2021 Aug 23;9(11):3934–3940.e9. doi: 10.1016/j.jaip.2021.08.007

Table E4.

Association between intranasal corticosteroids (iCS) use before and after propensity score (PS) matching using complete cases (ie, excluding patients with missing data and without imputation)

Variables Outcomes Total no. of patients Unadjusted OR [95% CI] No. of PS matched patients Adjusted OR [95% CI]
All patients
 Hospitalization 10,366 53,718 0.85 [0.80; 0.90] 9538 0.75 [0.70; 0.81]
 ICU admission 2,575 53,718 0.76 [0.68; 0.85] 9538 0.74 [0.64; 0.85]
 Hospital mortality 1,549 53,718 0.79 [0.68; 0.91] 9538 0.73 [0.61; 0.88]
Excluding iCS
 Hospitalization 8,833 49,059 0.73 [0.68; 0.78] 7828 0.72 [0.66; 0.78]
 ICU admission 2,135 49,059 0.60 [0.52; 0.69] 7828 0.59 [0.50; 0.70]
 Hospital mortality 1,275 49,059 0.65 [0.54; 0.77] 7828 0.63 [0.51; 0.78]
Subgroup with AEC
 Hospitalization 6,547 27,983 0.80 [0.74; 0.85] 6465 0.79 [0.73; 0.86]
 ICU admission 1,550 27,983 0.75 [0.65; 0.85] 6465 0.71 [0.60; 0.84]
 Hospital mortality 1,096 27,983 0.68 [0.57; 0.79] 6465 0.67 [0.55; 0.82]
Excluding patients with AR
 Hospitalization 9,422 47,650 0.82 [0.77; 0.88] 6580 0.71 [0.65; 0.77]
 ICU admission 2,367 47,650 0.77 [0.67; 0.87] 6580 0.75 [0.63; 0.88]
 Hospital mortality 1,416 47,650 0.76 [0.64; 0.90] 6580 0.73 [0.59; 0.90]

AEC, Angiotensin-converting enzyme; AR, allergic rhinitis; CI, confidence interval; ICU, Intensive care unit; OR, odds ratio.